{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:49:56Z","timestamp":1767980996058,"version":"3.49.0"},"reference-count":49,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,11,12]],"date-time":"2007-11-12T00:00:00Z","timestamp":1194825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pineal Research"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Circadian rhythmicity impairment reportedly becomes significant as a tumor progresses, while the incidence of cancer can be affected by disruption of the circadian system. Melatonin has oncostatic effects on several types of cancer (breast, prostate, and colorectal cancers), while it can be self\u2010defeating in others, such as lymphoma. Melanoma is one of the most aggressive cancers in humans; however, it seems to respond positively to melatonin in vitro<jats:italic>.<\/jats:italic> The present work tested whether body temperature (BT) rhythms are impaired by tumor progression, and whether exogenous melatonin restricts tumor growth and restores circadian rhythmicity; therefore, enhancing survival. To this end, C57 mice were intraperitoneal implanted with a temperature data logger and subcutaneously inoculated with melanoma cells. Animals were then submitted to light\u2013dark (LD) 12:12 cycles or continuous light (LL), with or without melatonin administration. Under LD light conditions, the BT rhythm exhibited a marked reduction in the first circadian harmonic amplitude, and increased phase instability (Rayleigh vector) as the tumor progressed. Melatonin administration (2\u2003mg\/kg BW\/day), on the other hand, increased the BT rhythm amplitude and phase stability, reduced tumor weight and prevented intraperitoneal dissemination. Exposure to LL induced a free\u2010running rhythm (1500\u2003min), significantly increasing tumor malignity, and therefore reducing survival. Surprisingly, the highest tumor weights and morbidity by metastasis were seen in the LL group treated with melatonin probably because this indoleamine was being administered at different subjective hours to free\u2010running animals. Circadian rhythmicity can thus be used as a marker rhythm for tumor progression, as rhythm impairment increases along with tumor malignancy. While melatonin administration improves rhythmicity and enhances survival under LD conditions, the results are self\u2010defeating when they coexist with circadian disruption as it occurs under LL. This emphasizes the importance of taking into account endogenous rhythmicity and limiting melatonin administration to the subjective night in order to restrict melanoma progression.<\/jats:p>","DOI":"10.1111\/j.1600-079x.2007.00531.x","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T16:50:31Z","timestamp":1195145431000},"page":"307-315","source":"Crossref","is-referenced-by-count":45,"title":["Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma\u2010bearing C57BL6 mice"],"prefix":"10.1111","volume":"44","author":[{"given":"B. B.","family":"Ot\u00e1lora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Rol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(72)90054-6"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.6.1583"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-185X.1996.tb01278.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/07420529909116858"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/074873040101600107"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3413487"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(97)00263-1"},{"key":"e_1_2_7_9_2","first-page":"3038","article-title":"Marked 24\u2010h rest\/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status","volume":"6","author":"Mormont MC","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_10_2","first-page":"1243","article-title":"Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcome","volume":"22","author":"Mormont MC","year":"2002","journal-title":"Anticancer Res"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0369-8114(03)00034-8"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0674"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.20.1563"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008983416836"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.20.1563"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2006.00325.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1999.tb00574.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199702000-00005"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200104000-00016"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:27:2:179"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013301408464"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.98106s1289"},{"key":"e_1_2_7_24_2","first-page":"57","article-title":"Melatonin: a potent, endogenous hydroxyl radical scavenger","volume":"1","author":"Tan DX","year":"1993","journal-title":"Endocrine J"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2006.00379.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2007.00432.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2006.00407.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(01)00059-0"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026023394407"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0959-9673.2006.00474.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2007.00451.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(01)00634-7"},{"key":"e_1_2_7_33_2","first-page":"24","article-title":"Oncostatic action of melatonin: facts and question marks","volume":"1","author":"Pawlikowski M","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/01926230390257885"},{"key":"e_1_2_7_35_2","first-page":"11","article-title":"Melanoma B16. Estudio cl\u00ednico\u2010patol\u00f3gico, ultraestructural y del comportamiento biol\u00f3gico","volume":"78","author":"G\u00f3mez M","year":"1987","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00114-003-0468-6"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.12.994"},{"key":"e_1_2_7_38_2","first-page":"511","article-title":"Light contamination during the dark phase in \u201cphotoperiodically controlled\u201d animal rooms: effect on tumor growth and metabolism in rats","volume":"47","author":"Dauchy RT","year":"1997","journal-title":"Lab Ani Sci"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2003.00004.x"},{"issue":"2","key":"e_1_2_7_40_2","first-page":"79","article-title":"Comments on the international symposium on light, endocrine systems and cancer","volume":"23","author":"Portier CJ","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(98)00273-3"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00360.2001"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/074873098129000228"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.3109\/07420529009059149"},{"key":"e_1_2_7_45_2","first-page":"4175","article-title":"Effect of melatonin on B16 melanoma growth in athymic mice","volume":"45","author":"Narita T","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01256752"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-6603-z"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0177"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.9.690"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11040"}],"container-title":["Journal of Pineal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-079X.2007.00531.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-079X.2007.00531.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:53:19Z","timestamp":1697046799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-079X.2007.00531.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,12]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1600-079X.2007.00531.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-079x.2007.00531.x","archive":["Portico"],"relation":{},"ISSN":["0742-3098","1600-079X"],"issn-type":[{"value":"0742-3098","type":"print"},{"value":"1600-079X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,12]]}}}